Drowsy 68-Year-Old on a New Thiazide with Sodium 116
A 68-year-old retired schoolteacher is brought to the emergency department by his wife with two days of vomiting, drowsiness, and one episode of confusion at home. He has hypertension and was started on hydrochlorothiazide 25 mg once daily three weeks ago; his only other medicines are amlodipine 5 mg and atorvastatin 10 mg. On examination he is drowsy but rousable, afebrile, pulse 88/min, BP 132/78 mmHg without a postural drop, no pedal oedema, no goitre, and no focal neurological deficit. Investigations: serum sodium 116 mmol/L, potassium 3.1 mmol/L, chloride 84 mmol/L, bicarbonate 24 mmol/L, urea 22 mg/dL, creatinine 0.9 mg/dL, serum osmolality 258 mOsm/kg, urine osmolality 470 mOsm/kg, urine sodium 62 mmol/L, TSH 2.1 mIU/L, morning cortisol 16 micrograms/dL, random glucose 96 mg/dL. Liver function tests and chest radiograph are normal. He is passing urine and is clinically euvolemic.
1. Which mechanism best explains the hyponatremia, and how do the urine and blood results let you exclude SIADH, adrenal insufficiency, and pseudohyponatremia?
Read the worked answer
Answer: thiazide-induced hyponatremia with concomitant thiazide-induced hypokalemia.
Reasoning step by step:
- True hypo-osmolar hyponatremia. Serum osmolality is 258 mOsm/kg, so this is not pseudohyponatremia (normal osmolality, seen with hyperproteinemia/hyperlipidemia) and not dilutional hyponatremia from hyperglycemia (glucose 96 mg/dL).
- The urine is inappropriately concentrated (470 mOsm/kg) with a high urine sodium (62 mmol/L) in a clinically euvolemic man - the biochemical signature of ADH-driven water retention. That pattern is expected with thiazides and does not by itself mean SIADH: thiazides block the diluting segment, cause mild natriuresis and volume contraction, and thereby stimulate ADH. The discriminator is the timeline - a drug started three weeks earlier in an elderly patient is the classic precipitant.
- SIADH is a diagnosis of exclusion and requires normal thyroid and adrenal function with no diuretic exposure. TSH is normal, and cortisol 16 micrograms/dL with hypokalemia (not hyperkalemia) rules out adrenal insufficiency - Addison disease would give hyperkalemia and often hyperpigmentation.
- Hypokalemia 3.1 mmol/L is itself a driver: potassium depletion causes sodium to shift into cells, deepening the hyponatremia, and it is an independent risk factor for osmotic demyelination.
So: do not label this SIADH; the correct label is drug-induced hyponatremia. Management of the drug cause, not fluid restriction, is the priority.
2. Give your correction plan for the first 24 hours, including the fluid, the rate, and exactly what you would do if the sodium rose by 14 mmol/L in 12 hours.
Read the worked answer
He is symptomatic (vomiting, confusion) - this is an emergency, but not a seizure/coma emergency.
First 24 hours:
- Secure IV access, cardiac monitor, hourly neurological observations, catheter to measure output.
- 3% NaCl 100–150 mL IV over 20 minutes, repeated up to two more times, until symptoms improve or the sodium has risen by 4–6 mmol/L. That acute rise is what treats cerebral oedema; the aim is not to normalise the sodium.
- Once symptoms improve, stop the hypertonic bolus and switch to a slow target: no more than 8 mmol/L in 24 hours (the lower end of the 8–10 range, because he is elderly, hypokalemic and vomiting - all osmotic demyelination risk factors). Check sodium every 2 hours during active correction, then 4–6 hourly.
- Correct potassium cautiously: every 1 mmol/L rise in potassium will also pull sodium up, and this is a common cause of unplanned overcorrection. Treat the vomiting, and stop the thiazide immediately.
- Avoid vasopressin antagonists acutely in a symptomatic patient; they are unpredictable here.
If sodium rises 14 mmol/L in 12 hours - this is overcorrection:
- Stop all sodium-containing fluids.
- Give 5% dextrose 10 mL/kg over 1 hour plus desmopressin 2 micrograms IV/subcutaneously to lock the kidneys and re-lower the sodium.
- Recheck sodium hourly and aim to bring it back to ≤8 mmol/L above the baseline of 116, i.e. ≤124 mmol/L in the first 24 hours. Relowering within the first 24 hours is the intervention that prevents osmotic demyelination, so act at once rather than observing.
3. What drug changes and follow-up would you arrange at discharge, and what would you tell the patient about recurrence?
Read the worked answer
At discharge:
- Stop hydrochlorothiazide permanently and do not substitute another thiazide or thiazide-like agent (chlorthalidone, indapamide) - cross-reactivity is high.
- Control the blood pressure with up-titration of amlodipine to 10 mg (or add an ACE inhibitor/ARB if needed). Remember that ACE inhibitors/ARBs also cause hyperkalemia and can aggravate hyponatremia, so if one is added the sodium must be rechecked.
- Review all other agents that can lower sodium - SSRIs, carbamazepine, PPIs, desmopressin - and avoid them.
- Check sodium and potassium at 48–72 hours and again at one week. His potassium of 3.1 mmol/L at presentation will need rechecking and oral replacement as an outpatient.
Counselling points:
- Thiazide hyponatremia can recur on rechallenge in a large proportion of patients, so he must tell every future prescriber that he had a sodium of 116 on a "water tablet".
- Sick-day rules: hold the thiazide (and any ACE inhibitor) if he has vomiting, diarrhoea or poor intake, and seek review early - this was likely precipitated by the vomiting episode.
- Risk factors to explain: age over 65, low body weight, female sex, and hypokalemia are all recognised predisposing factors; he has at least two.
The judgement point examiners test here is that the offending drug, not the sodium number, is the discharge problem.